// App-Quantinova.ai

1903 : Minimal Residual Disease Assessment and Allogeneic Transplantation As Consolidation Therapy in Acute Lymphoblastic Leukemia

Researchers

Presenter

  • Jf Combariza

Principal Investigators

  • Leonardo Bautista Toloza

  • M Arango

  • L Diaz

  • Claudia Agudelo Lopez

  • Vladimir Avila

  • Sonia Milena Hernandez

  • Guillermo Len-Basantes

  • Ana Maria Madera Rojas

  • Jaime valds-Cespedes

  • Fabin Mejia

  • Liliana Moreno

  • Rocio Orduz R

  • Jl Tovar-Bobadilla

  • Carlos Alberto Ramirez

Medical Centers

  • Hematology´s Department. Clínica Colsanitas. Keralty, BOGOTA, Colombia

  • Hematology`s Department, Hospital Pablo Tobón Uribe, Medellín, Colombia

  • Hematology´s Department. Clínica Colsanitas. Keralty, BOGOTA, Colombia

Locations

  • Colombia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved